Literature DB >> 27774526

The Inflammatory Cytokine IL-21 is Expressed by Splenic Neutrophils in Response to Transplantation of Allogeneic Cells.

John S Thompson1, Debra L Hardin2, Judy F Glass3, Joshua Dziba3, Jeffrey Campion4, Stephen A Brown1.   

Abstract

We have previously reported that GR-1 neutrophil/monocytes rose dramatically in the spleen, peaked by day 7 and declined through day 14. This period corresponded to the peak of acute Graft-Versus-Host Disease (aGVHD) in BALB/c mice transplanted with allogeneic donor cells. We now asked: what cytokines did these splenic neutrophil/monocytes express on day 7 and 14 post transplant? BALB/c mice were transplanted with allogeneic B6 or syngeneic BALB/c donor cells. Long term survival was recorded through day 31. Other groups were sacrificed on days 3, 5, 7, 14, 21 and 31 days post transplant to record the total number of cells in the spleens and their phenotypes. Neutrophils were isolated from the spleens of mice transplanted with B6 and BALB/c cells on days 7 and 14. Daily body weight demonstrated a transient drop in the syngeneic transplants on day 2 but a much greater drop with its nadir at day 7 and never fully recovering through 31 days. CD8/CD4 T lymphocytes peaked in the spleen on day 5 and were followed on day 7 by GR-I cells in all of the allogeneic transplants. In syngeneic transplants this early rise in lymphocytes did not occur and GR-1 cells peaked on day 14. Highly purified neutrophils were isolated in two separate experiments from the spleens on days 7 and 14 post transplant. In both experiments day 7 allogeneic neutrophils expressed significantly elevated levels of Interleukin-21 (IL-21) mRNA whereas the day 7 and 14 syngeneic cells expressed lower but significant levels of TNFα. Intracellular IL-21 was demonstrated in the allogeneic neutrophils on day 7 before and after in vitro stimulation. In conclusion Purified neutrophils isolated from the spleen on day 7, the early peak of allogeneic transplantation a GVHD, express high levels of IL-21 message and intracellular IL-21.

Entities:  

Keywords:  Allogeneic neutrophils; Graft-versus-host disease; IL-21; Transplantation

Year:  2016        PMID: 27774526      PMCID: PMC5070384          DOI: 10.15226/2372-0948/4/1/00144

Source DB:  PubMed          Journal:  SOJ Immunol


  42 in total

1.  Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways.

Authors:  Masahide Miyamoto; Olof Prause; Margareta Sjöstrand; Martti Laan; Jan Lötvall; Anders Lindén
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 2.  Neutrophils in innate and adaptive immunity.

Authors:  Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

Review 3.  Neutrophilic inflammation in severe asthma.

Authors:  Kazuyuki Nakagome; Sho Matsushita; Makoto Nagata
Journal:  Int Arch Allergy Immunol       Date:  2012-05-15       Impact factor: 2.749

4.  On the detection of neutrophil-derived vascular endothelial growth factor (VEGF).

Authors:  P Scapini; F Calzetti; M A Cassatella
Journal:  J Immunol Methods       Date:  1999-12-17       Impact factor: 2.303

5.  Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Authors:  Lauren A Licata; Cang T Nguyen; Rachel A Burga; Vincent Falanga; N Joseph Espat; Alfred Ayala; Mitchell Thorn; Richard P Junghans; Steven C Katz
Journal:  J Leukoc Biol       Date:  2013-07-24       Impact factor: 4.962

6.  Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection.

Authors:  Jessica L Werner; Melissa A Gessner; Lauren M Lilly; Michael P Nelson; Allison E Metz; Dawn Horn; Chad W Dunaway; Jessy Deshane; David D Chaplin; Casey T Weaver; Gordon D Brown; Chad Steele
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

7.  Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.

Authors:  Kymberly M Gowdy; Julia L Nugent; Tereza Martinu; Erin Potts; Laurie D Snyder; W Michael Foster; Scott M Palmer
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-29       Impact factor: 6.914

Review 8.  The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease.

Authors:  Thomas T MacDonald; Iona Bell; Giovanni Monteleone
Journal:  Biochem Soc Trans       Date:  2011-08       Impact factor: 5.407

9.  Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.

Authors:  Jörg H W Distler; Astrid Jüngel; Otylia Kowal-Bielecka; Beat A Michel; Renate E Gay; Haiko Sprott; Marco Matucci-Cerinic; Meike Chilla; Kristian Reich; Joachim R Kalden; Ulf Müller-Ladner; Hanns M Lorenz; Steffen Gay; Oliver Distler
Journal:  Arthritis Rheum       Date:  2005-03

10.  GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.

Authors:  Bijay Parajuli; Yoshifumi Sonobe; Jun Kawanokuchi; Yukiko Doi; Mariko Noda; Hideyuki Takeuchi; Tetsuya Mizuno; Akio Suzumura
Journal:  J Neuroinflammation       Date:  2012-12-13       Impact factor: 8.322

View more
  1 in total

1.  Targeting Cytokines in GVHD Therapy.

Authors:  Sandeep Kumar; Hemn Mohammadpour; Xuefang Cao
Journal:  J Immunol Res Ther       Date:  2017-06-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.